Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | -1.32% | 18.76 | 2.0% | $166.39m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.82% | 115.15 | 18.6% | $161.00m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.84% | 136.03 | 2.3% | $110.58m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 3.29% | 176.00 | 6.3% | $94.31m | |
| SAGE | SAGE Therapeutics, Inc. | 3.62% | 157.98 | 8.8% | $90.34m | |
| HZNP | Horizon Pharma plc | 0.11% | 27.91 | 7.3% | $86.93m | |
| PRGO | Perrigo Co. Plc | 0.39% | 48.54 | 6.8% | $68.17m | |
| ICLR | ICON Plc | 0.06% | 136.75 | 4.1% | $58.96m | |
| MNK | Mallinckrodt Plc | 0.59% | 23.80 | 21.0% | $55.65m | |
| UTHR | United Therapeutics Corporation | 1.44% | 122.99 | 14.3% | $55.20m | |
| PTLA | Portola Pharmaceuticals, Inc. | 2.13% | 33.63 | 7.6% | $45.58m | |
| AERI | Aerie Pharmaceuticals, Inc. | 7.39% | 49.25 | 6.9% | $41.81m | |
| MYOK | MyoKardia, Inc. | 2.42% | 55.82 | 2.4% | $37.75m | |
| ENDP | Endo International Plc | 0.34% | 8.76 | 8.9% | $37.73m | |
| MDCO | Medicines Company | 3.59% | 28.02 | 21.8% | $30.85m |
Company Profile
SAGE Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.